Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold

Journal of Materials Science: Materials in Medicine

Volumn 21, Issue 1, 2010, Pages 309-317

  Chen, Lei ^a   He, Zhengquan ^a   Chen, Bing ^c   Yang, Maojin ^b   Zhao, Yannan ^c   Sun, Wenjie ^c   Xiao, Zhifeng ^c   Zhang, Jing ^c   Dai, Jianwu ^c  

^a CHINA THREE GORGES UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BIOLOGICAL ACTIVITIES; CROSSLINKED; DEMINERALIZED BONE MATRIX; HAEMATOXYLIN; IMMUNOHISTOCHEMISTRY; METHYLAMINOPROPYL; MICROVESSELS; N-HYDROXYSUCCINIMIDE; POROUS TISSUE; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION;

BIOACTIVITY; BLOOD VESSELS; BONE; CROSSLINKING; ENDOTHELIAL CELLS; OXYGEN; POLYSACCHARIDES; SELF ASSEMBLY; TISSUE ENGINEERING;

SCAFFOLDS;

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; COLLAGEN; EOSIN; H 4784; HEMATOXYLIN; HEPARIN; N HYDROXYSUCCINIMIDE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; BONE DEMINERALIZATION; BONE MATRIX; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CROSS LINKING; DRUG DESIGN; DRUG IMPLANTATION; ENDOTHELIUM CELL; HEPARINIZATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROVASCULARIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; RAT; SUSTAINED DRUG RELEASE;

ANIMALS; BONE DEMINERALIZATION TECHNIQUE; BONE MATRIX; BONE REGENERATION; BONE SUBSTITUTES; CATTLE; CELLS, CULTURED; CROSS-LINKING REAGENTS; EFFICIENCY; GUIDED TISSUE REGENERATION; HEPARIN; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; POROSITY; RATS; RATS, SPRAGUE-DAWLEY; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 75049084712     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-009-3827-9     Document Type: Article

References (43)

1. H Iwata S Sakano T Itoh TW Bauer 2002 Demineralized bone matrix and native bone morphogenetic protein in orthopaedic surgery Clin Orthop Relat Res 395 1 99 109 10.1097/00003086-200202000-00010 11937869
2. J Glowacki LB Kaban JE Murray J Folkman JB Mulliken 1981 Application of the biological principle of induced osteogenesis for craniofacial defects Lancet 1 8227 959 962 10.1016/S0140-6736(81)91730-X 1:STN:280:DyaL3M7ps1aitA%3D%3D 6112384
3. CH Trevisiol RT Turner JE Pfaff JC Hunter PJ Menagh K Hardin, et al. 2007 Impaired osteoinduction in a rat model for chronic alcohol abuse Bone 41 2 175 180 10.1016/j.bone.2007.04.189 1:CAS:528:DC%2BD2sXnsFKku7s%3D 17567549 (Pubitemid 47001812)
4. DA Bomback JN Grauer R Lugo N Troiano T Patel GE Friedlaender 2004 Comparison of posterolateral lumbar fusion rates of Grafton Putty and OP-1 Putty in an athymic rat model Spine 29 15 1612 1617 10.1097/01.BRS.0000132512.53305. A1 15284503 (Pubitemid 39014835)
5. MA Morone SD Boden 1998 Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel Spine 23 2 159 167 10.1097/00007632- 199801150-00003 1:STN:280:DyaK1c7jsFSlsw%3D%3D 9474720 (Pubitemid 28128148)
6. GJ Martin Jr SD Boden L Titus NL Scarborough 1999 New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis Spine 24 7 637 645 10.1097/00007632- 199904010-00005 10209791 (Pubitemid 29162905)
7. AB Rabie 1997 Vascular endothelial growth pattern during demineralized bone matrix induced osteogenesis Connect Tissue Res 36 4 337 345 10.3109/03008209709160232 1:STN:280:DyaK1c3nt1CntQ%3D%3D 9610891
8. Y Zhao B Chen H Lin W Sun W Zhao J Zhang, et al. 2009 The bone-derived collagen containing mineralized matrix for the loading of collagen-binding bone morphogenetic protein-2 J Biomed Mater Res 88 725 734 10.1002/jbm.a.31928
9. B Chen H Lin Y Zhao B Wang Y Zhao Y Liu, et al. 2007 Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide J Biomed Mater Res 80 2 428 434 10.1002/jbm.a.30900 (Pubitemid 46122677)
10. M Lu AB Rabie 2002 The effect of demineralized intramembranous bone matrix and basic fibroblast growth factor on the healing of allogeneic intramembranous bone grafts in the rabbit Arch Oral Biol 47 12 831 841 10.1016/S0003-9969(02)00119-X 1:CAS:528:DC%2BD38XovFGgtr0%3D 12450514 (Pubitemid 41123015)
11. J Wittbjer B Palmer M Rohlin KG Thorngren 1983 Osteogenetic activity in composite grafts of demineralized compact bone and marrow Clin Orthop Relat Res 173 1 229 238 6218949
12. M Klagsbrun MA Moses 1999 Molecular angiogenesis Chem biol 6 8 R217 R224 10.1016/S1074-5521(99)80081-7 1:CAS:528:DyaK1MXlsVynsLk%3D 10421764 (Pubitemid 29380763)
13. B Emad M Sherifel GM Basma RW Wong M Bendeus AB Rabie 2006 Vascular endothelial growth factor augments the healing of demineralized bone matrix grafts International journal of surgery(London, England) 4 3 160 166
14. FP van de Wijngaert MC Tas EH Burger 1987 Characteristics of osteoclast precursor-like cells grown from mouse bone marrow Bone Miner 3 2 111 123 3333147
15. P Carmeliet 2003 Angiogenesis in health and disease Nat Med 9 6 653 660 10.1038/nm0603-653 1:CAS:528:DC%2BD3sXktFOntbY%3D 12778163 (Pubitemid 36749213)
16. MI Goth E Hubina S Raptis GM Nagy BE Toth 2003 Physiological and pathological angiogenesis in the endocrine system Microsc Res Tech 60 1 98 106 10.1002/jemt.10248 1:CAS:528:DC%2BD3sXmvVSmtQ%3D%3D 12500266 (Pubitemid 36055238)
17. S Paku N Paweletz 1991 First steps of tumor-related angiogenesis Lab Invest 65 3 334 346 1:STN:280:DyaK3Mzms1yquw%3D%3D 1716330
18. N Ferrara HP Gerber J LeCouter 2003 The biology of VEGF and its receptors Nat Med 9 6 669 676 10.1038/nm0603-669 1:CAS:528:DC%2BD3sXktFOnur4%3D 12778165 (Pubitemid 36749215)
19. J Grunstein JJ Masbad R Hickey F Giordano RS Johnson 2000 Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature Mol Cell Biol 20 19 7282 7291 10.1128/MCB.20.19.7282- 7291.2000 1:CAS:528:DC%2BD3cXms1Cjur4%3D 10982845
20. J Li YP Zhang RS Kirsner 2003 Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix Microsc Res Tech 60 1 107 114 10.1002/jemt.10249 1:CAS:528:DC%2BD3sXmvVSmug%3D%3D 12500267 (Pubitemid 36055239)
21. T Boontheekul DJ Mooney 2003 Protein-based signaling systems in tissue engineering Curr Opin Biotechnol 14 5 559 565 10.1016/j.copbio.2003.08.004 1:CAS:528:DC%2BD3sXot12hsrg%3D 14580589 (Pubitemid 37298044)
22. X Hao EA Silva A Mansson-Broberg KH Grinnemo AJ Siddiqui G Dellgren, et al. 2007 Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction Cardiovasc Res 75 1 178 185 10.1016/j.cardiores.2007.03.028 1:CAS:528:DC%2BD2sXmt1yntLw%3D 17481597 (Pubitemid 46876668)
23. JJ van den Beucken XF Walboomers ST Nillesen MR Vos NA Sommerdijk TH van Kuppevelt, et al. 2007 In vitro and in vivo effects of deoxyribonucleic acid-based coatings funtionalized with vascular endothelial growth factor Tissue Eng 13 4 711 720 10.1089/ten.2006.0303 17373893 (Pubitemid 46651502)
24. FG Rocha CA Sundback NJ Krebs JK Leach DJ Mooney SW Ashley, et al. 2008 The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine Biomaterials 29 19 2884 2890 10.1016/j.biomaterials.2008.03.026 1:CAS:528:DC%2BD1cXlsV2mtb4%3D 18396329
25. RR Chen EA Silva WW Yuen DJ Mooney 2007 Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation Pharm Res 24 2 258 264 10.1007/s11095-006-9173-4 17191092 (Pubitemid 46072185)
26. M Sato M Ishihara M Ishihara N Kaneshiro G Mitani T Nagai, et al. 2007 Effects of growth factors on heparin-carrying polystyrene-coated atelocollagen scaffold for articular cartilage tissue engineering J Biomed Mater Res B Appl Biomater 83 1 181 188 17385220
27. HJ Chung HK Kim JJ Yoon TG Park 2006 Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery Pharm Res 23 8 1835 1841 10.1007/s11095-006-9039-9 1:CAS:528:DC%2BD28XnvVymtro%3D 16858650 (Pubitemid 44200547)
28. MJ Wissink R Beernink AA Poot GH Engbers T Beugeling WG van Aken, et al. 2000 Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices J Control Release 64 1-3 103 114 10.1016/S0168-3659(99)00145-5 1:CAS:528:DC%2BD3cXks1Glug%3D%3D 10640649 (Pubitemid 30035311)
29. D Gospodarowicz J Cheng 1986 Heparin protects basic and acidic FGF from inactivation J Cell Physiol 128 3 475 484 10.1002/jcp.1041280317 1:CAS:528:DyaL28XlvVelt78%3D 3528177
30. DB Pike S Cai KR Pomraning MA Firpo RJ Fisher XZ Shu, et al. 2006 Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF Biomaterials 27 30 5242 5251 10.1016/j.biomaterials.2006.05.018 1:CAS:528:DC%2BD28Xnt1KktLs%3D 16806456 (Pubitemid 44080293)
31. JE Park GA Keller N Ferrara 1993 The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF Mol Biol Cell 4 12 1317 1326 1:CAS:528:DyaK2cXitlOjur0%3D 8167412
32. A Lode A Reinstorf A Bernhardt C Wolf-Brandstetter U Konig M Gelinsky 2008 Heparin modification of calcium phosphate bone cements for VEGF functionalization J Biomed Mater Res 86 3 749 759 10.1002/jbm.a.31581 1:STN:280:DC%2BD1cvmslOrtw%3D%3D
33. CM Riley PW Fuegy MA Firpo XZ Shu GD Prestwich RA Peattie 2006 Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels Biomaterials 27 35 5935 5943 10.1016/j.biomaterials. 2006.08.029 1:CAS:528:DC%2BD28Xpt1yjtrc%3D 16950508 (Pubitemid 44349007)
34. GC Steffens C Yao P Prevel M Markowicz P Schenck EM Noah, et al. 2004 Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor Tissue Eng 10 9-10 1502 1509 1:CAS:528:DC%2BD2cXhtVSgurrJ 15588409
35. O Jeon SW Kang HW Lim J Hyung Chung BS Kim 2006 Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel Biomaterials 27 8 1598 1607 10.1016/j.biomaterials.2005.08.030 1:CAS:528:DC%2BD2MXht1Kksr%2FJ 16146647 (Pubitemid 41739585)
36. J Zhang L Ding Y Zhao W Sun B Chen H Lin, et al. 2009 Collagen-targeting vascular endothelial growth factor improves cardiac performance after myocardial infarction Circulation 119 13 1776 1784 10.1161/CIRCULATIONAHA.108.800565 1:CAS:528:DC%2BD1MXjslKlu7o%3D 19307480
37. JJ Yoon HJ Chung HJ Lee TG Park 2006 Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor J Biomed Mater Res 79 4 934 942 10.1002/jbm.a.30843 (Pubitemid 44915914)
38. O Rebai J Le Petit-Thevenin N Bruneau D Lombardo A Verine 2005 In vitro angiogenic effects of pancreatic bile salt-dependent lipase Arterioscler Thromb Vasc Biol 25 2 359 364 10.1161/01.ATV.0000151618.49109.bd 1:CAS:528: DC%2BD2MXmtFCmtg%3D%3D 15569825 (Pubitemid 40189158)
39. MW Laschke A Elitzsch B Vollmar P Vajkoczy MD Menger 2006 Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions Hum Reprod 21 1 262 268 10.1093/humrep/dei308 1:CAS:528: DC%2BD2MXht1OqtL7P 16172144 (Pubitemid 41794320)
40. RK Bruick SL McKnight 2001 Building better vasculature Genes Dev 15 19 2497 2502 10.1101/gad.931601 1:CAS:528:DC%2BD3MXnsV2gtbk%3D 11581154 (Pubitemid 32937859)
41. M Komori Y Tomizawa K Takada M Ozaki 2005 A single local application of recombinant human basic fibroblast growth factor accelerates initial angiogenesis during wound healing in rabbit ear chamber Anesth Analg 100 3 830 834 10.1213/01.ANE.0000144426.18235.5A 1:CAS:528:DC%2BD2MXhsF2lsb8%3D 15728075 table of contents (Pubitemid 40300084)
42. N Ferrara 2002 Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications Semin Oncol 29 6 Suppl 16 10 14 1:CAS:528:DC%2BD3sXlvFSqsQ%3D%3D 12516033 1940734
43. RK Jain 2002 Tumor angiogenesis and accessibility: role of vascular endothelial growth factor Semin Oncol 29 6 3 9 10.1016/S0093-7754(02)70063-8 1:CAS:528:DC%2BD3sXlvFSqsA%3D%3D 12516032